27 Mart \u2018D\u00fcnya Tedaviye Uyum G\u00fcn\u00fc\u2019 kapsam\u0131nda Kahramanmara\u015f\u2019ta d\u00fczenlenen etkinlikte uzmanlar, kronik hastal\u0131klarda tedaviye uyumun art\u0131r\u0131lmas\u0131n\u0131n hayati \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131na dikkat \u00e7ekti. Prof. Dr. Mustafa Araz ve Prof. Dr. Oktay Ergene, hipertansiyon, diyabet ve obezite gibi hastal\u0131klar\u0131n kontrol alt\u0131na al\u0131nmamas\u0131 halinde ciddi komplikasyonlara ve erken \u00f6l\u00fcmlere yol a\u00e7t\u0131\u011f\u0131n\u0131 vurgulad\u0131.<\/p>\n
27 Mart \u2018D\u00fcnya Tedaviye Uyum G\u00fcn\u00fc\u2019 kapsam\u0131nda Kahramanmara\u015f K\u0130GEM Kad\u0131n \u0130\u015fg\u00fcc\u00fcn\u00fc Geli\u015ftirme Merkezi\u2019nde Prof. Dr. Mustafa Araz ve Prof. Dr. Oktay Ergene, Servier T\u00fcrkiye\u2019nin ko\u015fulsuz katk\u0131lar\u0131yla T\u00fcrkiye\u2019de ilk defa 14 derne\u011fin i\u015f birli\u011fi ile hayata ge\u00e7en \u201cT\u00fcrkiye 2030\u2019da y\u00fczde 50\u201d projesi kapsam\u0131nda vatanda\u015flarla bir araya geldi. Hasta, hasta yak\u0131n\u0131, sa\u011fl\u0131k profesyonelinin kat\u0131ld\u0131\u011f\u0131 ve kat\u0131l\u0131mc\u0131lar\u0131n tansiyon de\u011ferlerinin \u00f6l\u00e7\u00fclmesiyle ba\u015flayan etkinli\u011fin moderat\u00f6rl\u00fc\u011f\u00fcn\u00fc tiyatro sanat\u00e7\u0131s\u0131-y\u00f6netmen Mert \u00d6ner yapt\u0131.<\/p>\n
Klinik Endokrinoloji ve Diyabet Derne\u011fi Ba\u015fkan\u0131 Prof. Dr. Mustafa Araz,\u00a0<\/strong>D\u00fcnya Tedaviye Uyum G\u00fcn\u00fc kapsam\u0131nda yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, kronik hastal\u0131klarda tedaviye uyumun kritik \u00f6neme sahip oldu\u011funu belirtti. Kronik hastal\u0131klar\u0131n uzun vadede organ ve dokularda ciddi hasarlara yol a\u00e7t\u0131\u011f\u0131n\u0131 ifade eden Araz, \u201cEn s\u0131k g\u00f6r\u00fclen hastal\u0131klar aras\u0131nda hipertansiyon ve diyabet yer al\u0131yor. Bu hastal\u0131klar; kalp, damar, b\u00f6brek ve sinir sistemi gibi bir\u00e7ok organda hasara neden olarak uzun vadeli komplikasyonlara ve \u00f6l\u00fcm riskinde art\u0131\u015fa yol a\u00e7\u0131yor\u201d dedi.<\/p>\n “T\u00fcrkiye\u2019de kronik hastal\u0131k oranlar\u0131 y\u00fcksek”<\/p>\n T\u00fcrkiye\u2019de hipertansiyonun eri\u015fkin n\u00fcfusun yakla\u015f\u0131k y\u00fczde 31\u2019inde, diyabetin ise y\u00fczde 16\u2019s\u0131nda g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc aktaran Araz, bu oranlar\u0131n y\u00fcksekli\u011fine dikkat \u00e7ekti. Kontrol oranlar\u0131n\u0131n ise istenilen seviyede olmad\u0131\u011f\u0131n\u0131 vurgulayan Araz, kronik hastal\u0131klarda hedef de\u011ferlere ula\u015fma oran\u0131n\u0131n y\u00fczde 30-40 civar\u0131nda oldu\u011funu kaydetti.<\/p>\n “T\u00fcrkiye\u2019de tedaviye uyum oran\u0131 y\u00fczde 36”<\/p>\n Tedaviye uyumun hem d\u00fcnyada hem de T\u00fcrkiye\u2019de yeterli d\u00fczeyde olmad\u0131\u011f\u0131n\u0131 dile getiren Araz, \u201cHastalar\u0131n tedaviye uyum oran\u0131 d\u00fcnya genelinde y\u00fczde 30 ila 50 aras\u0131nda. T\u00fcrkiye\u2019de ise bu oran yakla\u015f\u0131k y\u00fczde 36 seviyesinde\u201d diye konu\u015ftu.<\/p>\n “Uyum artarsa \u00f6l\u00fcm ve komplikasyonlar azal\u0131yor”<\/p>\n Tedaviye uyumun art\u0131r\u0131lmas\u0131n\u0131n \u00f6nemli kazan\u0131mlar sa\u011flayaca\u011f\u0131n\u0131 vurgulayan Araz, \u201cTedaviye uyum sayesinde \u00f6l\u00fcm oranlar\u0131nda yakla\u015f\u0131k y\u00fczde 21 azalma, organ hasar\u0131 ve komplikasyonlarda ise y\u00fczde 30 ila 50 oran\u0131nda d\u00fc\u015f\u00fc\u015f sa\u011flamak m\u00fcmk\u00fcn\u201d dedi.<\/p>\n “2030\u2019da tedavi ba\u015far\u0131 hedefi y\u00fczde 50”<\/p>\n 2030 y\u0131l\u0131na y\u00f6nelik hedeflere de de\u011finen Araz, tedaviye uyumu art\u0131rarak tedavi ba\u015far\u0131s\u0131nda art\u0131\u015fa y\u00f6nelik \u00e7al\u0131\u015fmalar y\u00fcr\u00fctt\u00fcklerini belirtti ve \u201cAmac\u0131m\u0131z T\u00fcrkiye\u2019de tedavi ba\u015far\u0131 oran\u0131n\u0131 diyabette y\u00fczde 36,7\u2019den, hipertansiyonda ise y\u00fczde 22,2\u2019den %50\u2019ye \u00e7\u0131karmak. Bu sayede hastal\u0131klar\u0131n uzun vadede olu\u015fturdu\u011fu zararlar\u0131 azaltmay\u0131 hedefliyoruz\u201d ifadelerini kulland\u0131.<\/p>\n \u00a0“Metabolik hastal\u0131klar erken \u00f6l\u00fcmlerin ba\u015fl\u0131ca nedeni”<\/p>\n Kalp Damar Hastal\u0131klar\u0131ndan Korunma ve Fark\u0131ndal\u0131k Derne\u011fi Ba\u015fkan\u0131 Prof. Dr. Oktay Ergene<\/strong>\u00a0ise diyabet, obezite ve hipertansiyonun birbiriyle ba\u011flant\u0131l\u0131 oldu\u011funu belirterek, bu hastal\u0131klar\u0131n kontrol alt\u0131na al\u0131nmamas\u0131 halinde erken \u00f6l\u00fcm riskinin ciddi \u015fekilde artt\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n Metabolik hastal\u0131klar\u0131n temelinde obezite ve glikoz kontrol bozuklu\u011funun yer ald\u0131\u011f\u0131n\u0131 belirten Ergene, \u201cDiyabet, kalp ve b\u00f6brek hastal\u0131klar\u0131 birbiriyle ili\u015fkili. Bu hastal\u0131klar orta ve uzun vadede ciddi organ hasarlar\u0131na yol a\u00e7arak d\u00fcnyada erken \u00f6l\u00fcmlerin en \u00f6nemli nedenlerinden biri haline geliyor\u201d dedi.<\/p>\n “50 ya\u015f sonras\u0131 risk h\u0131zla art\u0131yor”<\/p>\n ABD\u2019de yap\u0131lan bir ara\u015ft\u0131rmaya de\u011finen Oktay Ergene, belirli ya\u015f\u0131n \u00fczerindeki bireylerde bu hastal\u0131klardan en az birinin g\u00f6r\u00fclme oran\u0131n\u0131n y\u00fczde 90\u2019lar\u0131n \u00fczerine \u00e7\u0131kt\u0131\u011f\u0131n\u0131 belirterek, \u201c50 ya\u015f sonras\u0131 10 ki\u015fiden 9\u2019unda bu hastal\u0131klardan en az biri g\u00f6r\u00fcl\u00fcyor\u201d diye konu\u015ftu.<\/p>\n “T\u00fcrkiye\u2019de obezite ve diyabet oran\u0131 y\u00fcksek”<\/p>\n T\u00fcrkiye\u2019de obezite oran\u0131n\u0131n eri\u015fkin n\u00fcfusta y\u00fczde 36-40 seviyelerinde oldu\u011funu, diyabetin ise yakla\u015f\u0131k y\u00fczde 17 oran\u0131nda g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc aktaran Ergene, bu oranlar\u0131n Avrupa \u00fclkelerine k\u0131yasla olduk\u00e7a y\u00fcksek oldu\u011funa dikkat \u00e7ekti.<\/p>\n “T\u00fcrkiye\u2019de ya\u015fam s\u00fcresi daha k\u0131sa”<\/p>\n T\u00fcrkiye\u2019de ya\u015fam s\u00fcresinin geli\u015fmi\u015f \u00fclkelere g\u00f6re daha k\u0131sa oldu\u011funu vurgulayan Prof. Dr. Oktay Ergene, \u201cGeli\u015fmi\u015f \u00fclkelerde ortalama ya\u015fam s\u00fcresi 80\u2019li ya\u015flar\u0131n \u00fczerine \u00e7\u0131karken, T\u00fcrkiye\u2019de bu rakam 77 civar\u0131nda. Arada 10 y\u0131la varan farklar bulunuyor\u201d ifadelerini kulland\u0131.<\/p>\n “Sa\u011fl\u0131kl\u0131 ya\u015fam al\u0131\u015fkanl\u0131klar\u0131 erken ya\u015fta kazan\u0131lmal\u0131”<\/p>\n Hastal\u0131klar\u0131n \u00f6nlenmesinde sa\u011fl\u0131kl\u0131 ya\u015fam al\u0131\u015fkanl\u0131klar\u0131n\u0131n \u00f6nemine i\u015faret eden Ergene, ya\u015fam tarz\u0131n\u0131n gen\u00e7 ya\u015flarda d\u00fczenlenmesi gerekti\u011fini belirtti. Hastal\u0131k geli\u015ftikten sonra ise ila\u00e7 tedavisinin ka\u00e7\u0131n\u0131lmaz oldu\u011funu s\u00f6yledi.<\/p>\n “Hipertansiyon \u00e7o\u011fu zaman ciddiye al\u0131nm\u0131yor”<\/p>\n Hipertansiyonun \u00e7o\u011fu zaman hafife al\u0131nd\u0131\u011f\u0131n\u0131 dile getiren Prof. Dr. Oktay Ergene, \u201cHipertansiyon, d\u00fcnyadaki \u00f6l\u00fcmlerin ve kalp hastal\u0131klar\u0131n\u0131n \u00f6nemli bir k\u0131sm\u0131ndan sorumlu. Ancak toplumda yeterince ciddiye al\u0131nm\u0131yor ve ila\u00e7 kullan\u0131m\u0131 ihmal ediliyor. T\u00fcrkiye\u2019de sa\u011fl\u0131k sisteminde ilaca eri\u015fim \u00e7ok iyi durumda iken kronik hastal\u0131klar i\u00e7in d\u00fczenli ila\u00e7 kullan\u0131m oranlar\u0131m\u0131z \u00e7ok d\u00fc\u015f\u00fck.\u201d dedi.<\/p>\n “Tuz t\u00fcketiminin azalt\u0131lmas\u0131 \u00f6nemli”<\/p>\n Toplumsal \u00f6nlemlerin \u00f6nemine de de\u011finen Ergene, tuz t\u00fcketiminin azalt\u0131lmas\u0131n\u0131n hipertansiyonla m\u00fccadelede \u00f6nemli bir ad\u0131m oldu\u011funu belirtti.<\/p>\n “70 ya\u015f\u0131nda hipertansiyon oran\u0131 y\u00fczde 70”<\/p>\n \u0130leri ya\u015flarda hipertansiyon g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131n\u0131n artt\u0131\u011f\u0131n\u0131 ifade eden Ergene, \u201c30 ya\u015f\u0131ndaki bireylerde hipertansiyon g\u00f6r\u00fclme oran\u0131 %30 iken, 40 ya\u015f\u0131ndaki bireylerde %40, 70 ya\u015f\u0131ndaki bireylerde ise bu oran\u0131 %70\u2019i buluyor. Yani 10 ki\u015fiden 7\u2019sinde hipertansiyon var\u201d dedi.\u00a0<\/p>\n \u00a0“Tansiyon kontrol\u00fc hayati \u00f6nem ta\u015f\u0131yor”<\/p>\n Kan bas\u0131nc\u0131n\u0131n kontrol alt\u0131na al\u0131nmas\u0131n\u0131n hayati \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131 vurgulayan Ergene, \u201cG\u00fcn\u00fcm\u00fczde art\u0131k biliyoruz ki tansiyonun 130\/80 mmHg\u2019nin alt\u0131na indirilmesi gerekiyor. Aksi halde kalp krizi ve inme riski ciddi \u015fekilde art\u0131yor. Basit bir ila\u00e7 tedavisiyle bu riskleri b\u00fcy\u00fck \u00f6l\u00e7\u00fcde azaltmak m\u00fcmk\u00fcn\u201d diye konu\u015ftu.<\/p>\n \u201cTiyatro hat\u0131rlat\u0131r. Uyum ya\u015fat\u0131r.\u201d<\/p>\n Tiyatro sanat\u00e7\u0131s\u0131 Mert \u00d6ner<\/strong>\u00a0ise ayn\u0131 takvimde bulu\u015fan D\u00fcnya Tedaviye Uyum G\u00fcn\u00fc ve D\u00fcnya Tiyatro G\u00fcn\u00fc\u2019n\u00fcn adeta hayat\u0131n dengesine vurgu yapt\u0131\u011f\u0131n\u0131 s\u00f6yledi: \u201c27 Mart\u2019\u0131n iki anlam\u0131 var: D\u00fcnya Tiyatro G\u00fcn\u00fc ve Tedaviye Uyum G\u00fcn\u00fc. Ayn\u0131 g\u00fcnde bulu\u015fmalar\u0131, hayat\u0131n hem sahnede hem bedenimizde ayn\u0131 incelikli dengeyle akt\u0131\u011f\u0131n\u0131 hat\u0131rlat\u0131yor; bu rastlant\u0131n\u0131n i\u00e7inde tuhaf bir sevin\u00e7, derin bir anlam var. \u00a0 Sahne, insan\u0131n do\u011fayla yeniden ayn\u0131 ritmi arad\u0131\u011f\u0131 yerdir. Bir nefes, bir s\u00f6z, bir beden\u2026 \u00a0Hepsi g\u00f6r\u00fcnmeyen bir uyumun par\u00e7as\u0131. Tiyatro hat\u0131rlat\u0131r. Uyum ya\u015fat\u0131r. Hik\u00e2yeler ise unuttuklar\u0131m\u0131z\u0131 iyile\u015ftirir. Bizi birbirimize, topra\u011fa, hayata yeniden ba\u011flar. \u00c7\u00fcnk\u00fc d\u00fcnya, ancak hikayelerimizi payla\u015ft\u0131\u011f\u0131m\u0131z s\u00fcrece dengede kal\u0131r.\u201d diye konu\u015ftu.<\/p>\n \u201cT\u00fcrkiye 2030\u2019da y\u00fczde 50 projesi\u201d<\/p>\n D\u00fcnyada veriler her iki hastadan birinin tedaviye uyumsuz oldu\u011funu g\u00f6steriyor. D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc rakamlar\u0131na g\u00f6re d\u00fcnyada 1.3 milyar ki\u015fi hipertansiyon, 800 milyondan fazla ki\u015fi de diyabet hastas\u0131. Her 9 ki\u015fiden biri diyabetle ya\u015fad\u0131\u011f\u0131n\u0131n fark\u0131nda de\u011fil. OECD verileri, tedaviye uyumun artmas\u0131yla uzun d\u00f6nemde \u00f6l\u00fcm oranlar\u0131n\u0131n y\u00fczde 21 azalt\u0131labilece\u011fini g\u00f6steriyor. Ayn\u0131 ara\u015ft\u0131rma, y\u00fcksek hasta uyumunun sa\u011fl\u0131k harcamalar\u0131 \u00fczerinde y\u0131ll\u0131k 125 milyar Euro katk\u0131 sa\u011flayabilece\u011fini ortaya koymaktad\u0131r. \u00a0<\/p>\n T\u00fcrkiye\u2019de ise t\u00fcm eri\u015fkinlerin y\u00fczde 31\u2019i hipertansiyon, y\u00fczde 16,6\u2019si diyabet hastas\u0131. Hipertansiyon tedavisine ba\u015flayan hastalar\u0131n yar\u0131s\u0131 ilk iki y\u0131lda tedavilerini yar\u0131m b\u0131rak\u0131yor. Tedaviye uyum sa\u011flamayan hastalar\u0131n hastaneye yat\u0131\u015flar \u00fczerindeki art\u0131\u015f oran\u0131 y\u00fczde 20\u2019ye var\u0131yor. Alarm veren bu tablonun de\u011fi\u015fmesine katk\u0131 sa\u011flamak i\u00e7in hayata ge\u00e7en T\u00fcrkiye 2030\u2019da %50 projesi 13 uzmanl\u0131k 1 hasta derne\u011finin kat\u0131l\u0131m\u0131yla ortaya \u00e7\u0131kan ve hipertansiyon ve diyabet gibi kronik hastal\u0131klarda hastan\u0131n tedaviye uyumu ve tedavi ba\u015far\u0131s\u0131n\u0131n y\u00fckselmesini hedefleyen bir sosyal sorumluluk projesidir. \u00a0Servier T\u00fcrkiye\u2019nin ko\u015fulsuz destekledi\u011fi bu projenin amac\u0131 2030 y\u0131l\u0131na kadar hipertansiyonda %22,2, diyabette y\u00fczde 36,7 olan tedavi ba\u015far\u0131 oran\u0131n\u0131 %50\u2019ye \u00e7\u0131kartmakt\u0131r.<\/p>\n \u201c14 dernek ortak ama\u00e7 i\u00e7in birle\u015fti\u201d<\/p>\n Hipertansiyon ve diyabet gibi kronik hastal\u0131klarda tedaviye uyum oranlar\u0131n\u0131 y\u00fckselterek hastal\u0131k kontrol ba\u015far\u0131s\u0131n\u0131 2030’a kadar en az y\u00fczde 50’ye ula\u015ft\u0131rmay\u0131 hedefleyen bu projede, Ateroskleroz Derne\u011fi, Avrasya Kalp Yetersizli\u011fi Derne\u011fi, Dahiliye Uzmanlar\u0131 Derne\u011fi, \u0130\u00e7 Hastal\u0131klar\u0131 Uzmanl\u0131k E\u011fitim Ara\u015ft\u0131rma Derne\u011fi, Kalp Damar Hastal\u0131klar\u0131yla M\u00fccadele ve Fark\u0131ndal\u0131k Derne\u011fi, Kardiyovask\u00fcler Akademi Derne\u011fi, Klinik Endokrinoloji ve Diyabet Derne\u011fi, Metabolik Sendrom Derne\u011fi, T\u00fcrk Diyabet Cemiyeti, T\u00fcrk Giri\u015fimsel Kardiyoloji Vakf\u0131, T\u00fcrk Hipertansiyon ve B\u00f6brek Hastal\u0131klar\u0131 Derne\u011fi, T\u00fcrk \u0130\u00e7 Hastal\u0131klar\u0131 Uzmanl\u0131k Derne\u011fi, T\u00fcrkiye Diyabet Vakf\u0131, T\u00fcrkiye Endokrinoloji ve Metabolizma Derne\u011fi yer al\u0131yor. \u00a0<\/p>\n \u00a0<\/p>\n \u00a0<\/p>\n Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":" 27 Mart \u2018D\u00fcnya Tedaviye Uyum G\u00fcn\u00fc\u2019 kapsam\u0131nda Kahramanmara\u015f\u2019ta d\u00fczenlenen etkinlikte uzmanlar, kronik hastal\u0131klarda tedaviye uyumun art\u0131r\u0131lmas\u0131n\u0131n hayati \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131na dikkat \u00e7ekti.<\/p>\n","protected":false},"author":1,"featured_media":3581,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31],"tags":[],"class_list":["post-3580","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/posts\/3580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3580"}],"version-history":[{"count":1,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/posts\/3580\/revisions"}],"predecessor-version":[{"id":3582,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/posts\/3580\/revisions\/3582"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/media\/3581"}],"wp:attachment":[{"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}